Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/16/2021 | $48.00 | Overweight → Equal-Weight | Morgan Stanley |
| 8/18/2021 | $62.00 → $56.00 | Overweight | Morgan Stanley |
Morgan Stanley downgraded CDK Global from Overweight to Equal-Weight and set a new price target of $48.00
Morgan Stanley reiterated coverage of CDK Global with a rating of Overweight and set a new price target of $56.00 from $62.00 previously
Oppenheimer reiterated coverage of CDK Global with a rating of and set a new price target of $65.00 from $55.00 previously
SC 13G/A - CDK Global, Inc. (0001609702) (Subject)
SC 13G - CDK Global, Inc. (0001609702) (Subject)
SC 13G/A - CDK Global, Inc. (0001609702) (Subject)
4 - CDK Global, Inc. (0001609702) (Issuer)
4 - CDK Global, Inc. (0001609702) (Issuer)
4 - CDK Global, Inc. (0001609702) (Issuer)
HOFFMAN ESTATES, Ill., June 09, 2022 (GLOBE NEWSWIRE) -- CDK Global, Inc. (NASDAQ:CDK) has declared a regular quarterly cash dividend of $0.15 per share payable on June 29, 2022 to shareholders of record at the close of business on June 20, 2022. About CDK Global With approximately $2 billion in revenues, CDK Global (NASDAQ:CDK) is a leading provider of retail technology and software as a service (SaaS) solutions that help dealers and auto manufacturers run their businesses more efficiently, drive improved profitability and create frictionless purchasing and ownership experiences for consumers. Today, CDK serves over 15,000 retail locations in North America. For more information, visit c
Revenue Growth of 6% Year over Year HOFFMAN ESTATES, Ill., May 05, 2022 (GLOBE NEWSWIRE) -- CDK Global, Inc. (NASDAQ:CDK) today announced financial results for its fiscal 2022 third quarter ended March 31, 2022. Revenue of $459.7 million in the third quarter ended March 31, 2022Revenue growth of 6% year-over-year driven by both core and acquisition related businessesStrong subscription growth due to contributions from site growth, revenue-per-site growth and the increased adoption of modern retail capability at dealershipsGAAP Diluted earnings per share of $0.56; Non-GAAP Adjusted diluted earnings per share of $0.78Adjusted EBITDA year-over-year growth of 5% and EPS growth of 13%
HOFFMAN ESTATES, Ill., Feb. 03, 2022 (GLOBE NEWSWIRE) -- CDK Global, Inc. (NASDAQ:CDK) today announced financial results for its fiscal 2022 second quarter ended December 31, 2021. "We continued to see the benefit of our focus on product innovation and on customer success which resulted in another quarter of solid growth DMS sites and average revenue per site," said Brian Krzanich, CDK chief executive officer. "This growth is coming from both our core business and contributions from recent acquisitions. CDK is uniquely positioned as the center of the automotive retail ecosystem, and through our relentless focus on building connections through our SaaS solutions and investing in our vision
15-12G - CDK Global, Inc. (0001609702) (Filer)
8-K - CDK Global, Inc. (0001609702) (Filer)
S-8 POS - CDK Global, Inc. (0001609702) (Filer)
Sales and Operational Veteran Brings Additional Global Business Experience and Healthcare Technology Expertise to Board Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmacy care delivery model, today announced that the Board of Directors elected Eileen Voynick to the Board, effective January 5, 2024. Ms. Voynick fills the vacancy resulting from Sara J. White, a Class I director who stepped down from the Company's Board of Directors, effective January 5, 2024. In addition, the Company announced that Vance Moore will not stand for reelection to the Company's Board at Omnicell's 2024 annual meeting of stockholders (the "2024 annual meeting") and e
BringOz, the world's most complete delivery management system, today announced that it has become a participant in the CDK Global Partner Program. As a member of one of the largest third-party partner programs in the industry. BringOz is now part of a marketplace of applications and integrations that CDK Global, Inc. (NASDAQ:CDK), a leading enabler of end-to-end automotive commerce, developed to help automotive dealers succeed. "Integrating BringOz' solution with CDK's dealer management system enables automotive dealerships to simplify and streamline delivery management, save time and resources, and offer an efficient, convenient, and transparent delivery experience that today's customers
Dealer Pay, whose Point-of-Sale solutions provide modern payment acceptance to both auto and truck dealerships, today announced that it has become a participant in the CDK Global Partner Program. As a member of one of the largest third-party partner programs in the industry, DealerPay is now part of a marketplace of applications and integrations that CDK Global, Inc. (NASDAQ:CDK), a leading automotive retail technology company, developed to help automotive dealers succeed. CEO, Julie Douglas affirms, "Dealer Pay is honored to join the CDK Global Partner Program." As a vendor, Dealer Pay will provide payment solutions that streamline the sales process and improve the customer experience. De
Sales and Operational Veteran Brings Additional Global Business Experience and Healthcare Technology Expertise to Board Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmacy care delivery model, today announced that the Board of Directors elected Eileen Voynick to the Board, effective January 5, 2024. Ms. Voynick fills the vacancy resulting from Sara J. White, a Class I director who stepped down from the Company's Board of Directors, effective January 5, 2024. In addition, the Company announced that Vance Moore will not stand for reelection to the Company's Board at Omnicell's 2024 annual meeting of stockholders (the "2024 annual meeting") and e
OLYPHANT, Pa., April 8, 2021 /PRNewswire/ -- AGS Health, a leader in revenue cycle management solutions, today announced the appointment of Eileen Voynick as board chair. "I'm excited to join the AGS Health team at this pivotal time for growth," said Ms. Voynick. "I look forward to working closely with the leadership team in helping develop forward-thinking revenue cycle management strategies to achieve great results for healthcare providers, enabling them to invest further in care delivery," she noted. Eileen Voynick, AGS Health Board Chair With decades of experience in healthcare technology, life sciences and services, Ms. Voynick is an industry leader with a prove